Cargando…

Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS

BACKGROUND/AIM: The changes in the cerebrospinal fluid (CSF) metabolome associated with the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS) are poorly understood and earlier smaller studies have shown conflicting results. The metabolomic methodology is suitable for screening larg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wuolikainen, Anna, Moritz, Thomas, Marklund, Stefan L., Antti, Henrik, Andersen, Peter Munch
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070699/ https://www.ncbi.nlm.nih.gov/pubmed/21483737 http://dx.doi.org/10.1371/journal.pone.0017947

Ejemplares similares

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2015)

Untargeted GC/TOFMS unravel metabolic profiles in cerebrospinal fluid of Chinese people living with HIV
por: Keram, Alim, et al.
Publicado: (2021)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021)

Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes
por: Zhou, Jinxia, et al.
Publicado: (2023)

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis
por: Olesen, Mads Nikolaj, et al.
Publicado: (2020)

Towards Standardization of Data Normalization Strategies to Improve Urinary Metabolomics Studies by GC×GC-TOFMS
por: Nam, Seo Lin, et al.
Publicado: (2020)

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
por: Shi, Jiaying, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022)

Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations
por: Lange, Dale J., et al.
Publicado: (2017)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
por: Nakayama, Yui, et al.
Publicado: (2013)

Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis
por: Nukui, Takamasa, et al.
Publicado: (2021)

Improvement of Ylang-Ylang Essential Oil Characterization by GC×GC-TOFMS
por: Brokl, Michał, et al.
Publicado: (2013)

Analysis of Volatile Compounds in Pears by HS-SPME-GC×GC-TOFMS
por: Wang, Chenchen, et al.
Publicado: (2019)

Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients
por: Bräuer, Stefan, et al.
Publicado: (2020)

CRISP: a deep learning architecture for GC × GC–TOFMS contour ROI identification, simulation and analysis in imaging metabolomics
por: Mathema, Vivek Bhakta, et al.
Publicado: (2022)

Interplay of Metallome and Metabolome in Amyotrophic Lateral Sclerosis: A Study on Cerebrospinal Fluid of Patients Carrying Disease-Related Gene Mutations
por: Solovyev, Nikolay, et al.
Publicado: (2023)

Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function
por: Drannik, Anna, et al.
Publicado: (2017)

Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2020)

Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum
por: Janssens, Jana, et al.
Publicado: (2020)

Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients
por: Sass, Lucas R., et al.
Publicado: (2020)

Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression
por: Sol, Joaquim, et al.
Publicado: (2021)

Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients
por: Joilin, Greig, et al.
Publicado: (2022)

Searching for Potential Markers of Glomerulopathy in Urine by HS-SPME-GC×GC TOFMS
por: Ligor, Tomasz, et al.
Publicado: (2021)

The Metabolomic Profile of the Essential Oil from Zanthoxylum caribaeum (syn. chiloperone) Growing in Guadeloupe FWI using GC × GC-TOFMS
por: Farouil, Lea, et al.
Publicado: (2022)

Cronobacter sakazakii DNA Detection in Cerebrospinal Fluid of a Patient with Amyotrophic Lateral Sclerosis Mimic Syndrome
por: Piombo, Marianna, et al.
Publicado: (2015)

Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects
por: Wilson, Meghan E, et al.
Publicado: (2013)

Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis
por: Alonso, Ruth, et al.
Publicado: (2015)

Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
por: Bossolasco, Patrizia, et al.
Publicado: (2017)

Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis
por: Forsberg, Karin, et al.
Publicado: (2011)

GC × GC-TOFMS metabolomics analysis identifies elevated levels of plasma sugars and sugar alcohols in diabetic mellitus patients with kidney failure
por: Duangkumpha, Kassaporn, et al.
Publicado: (2022)

Development and validation of a GC × GC-ToFMS method for the quantification of pesticides in environmental waters
por: Romagnoli, Monica, et al.
Publicado: (2023)

Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
por: Otake, Kentaro, et al.
Publicado: (2019)

Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
por: Tokuda, Eiichi, et al.
Publicado: (2019)

Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis Patients
por: Bourbouli, Mara, et al.
Publicado: (2021)

Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis
por: Assialioui, Abdelilah, et al.
Publicado: (2022)

Tuberculosis is associated with sputum metabolome variations, irrespective of patient sex or HIV status: an untargeted GCxGC-TOFMS study
por: Beukes, Derylize, et al.
Publicado: (2023)

Myofiber Type Shift in Extraocular Muscles in Amyotrophic Lateral Sclerosis
por: Behzadi, Arvin, et al.
Publicado: (2023)

Distinguishing between Decaffeinated and Regular Coffee by HS-SPME-GC×GC-TOFMS, Chemometrics, and Machine Learning
por: Zou, Yun, et al.
Publicado: (2022)

Lipid Serum Profiling of Boar-Tainted and Untainted Pigs Using GC×GC–TOFMS: An Exploratory Study
por: Bhatt, Kinjal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d0r69ad9gn49vfn36bj0u4gke5